DBV Technologies

Page d'Accueil
France
Châtillon
DBV Technologies

DBV is committed to finding a safe and effective therapy for people living with food allergies

DBV technologies is a clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin®.

18/05/2026

A special moment for our team, as we were featured on the Nasdaq Tower in Times Square for ; a meaningful reminder of the families we aim to serve.

Moments like this help bring greater visibility to food allergies and reaffirm our dedication to advancing pediatric care.

Learn more about our mission here: https://bit.ly/3S6OALw

14/05/2026

Our team is coming together in teal this Food Allergy Awareness Week to show support for the food allergy community. Behind our work are people with lived experiences and personal connections, as parents, physicians, advocates, and individuals who understand the impact food allergies can have on everyday life.

We understand firsthand how food allergies may be unseen but should never be unnoticed. Sharing these perspectives is one way we continue to build awareness and strengthen our mission of advancing pediatric care.

Learn more about our team and commitment: https://bit.ly/47yp7Bs

08/05/2026

As part of our Peanut Allergy Dictionary series, we’re taking a closer look at “Anaphylaxis.”

A severe allergic reaction that can happen quickly and potentially become life-threatening after exposure to an allergen like peanuts. During anaphylaxis, the immune system releases a flood of chemicals that can cause symptoms like a sudden drop in blood pressure and narrowed airways that make breathing difficult.

What makes it especially challenging is how unpredictable reactions can be, varying in timing and severity; which is why awareness, and preparedness are so important for families living with food allergies. It's part of the daily reality many families navigate, and a reminder of why continued progress in food allergy care matters so much.

Learn more about how we're supporting children and families living with food allergies: https://dbv-technologies.com/our-science/

07/05/2026

For millions of families, food allergy is more than a diagnosis, it is a daily reality that requires constant awareness, preparation, and care.

This is a time to recognize the families navigating these conditions and the importance of continued education, advocacy, and support.

We’re proud to work alongside organizations including Allergy & Asthma Network, Asthma and Allergy Foundation of America (AAFA), Food Allergy Research & Education, The Food Allergy & Anaphylaxis Connection Team, FAACT, and Food Allergy Canada.

At DBV Technologies, this work is deeply personal, and we remain focused on advancing pediatric care.

23/04/2026

As a parent, managing your child's often means you have to be thinking ahead. Some of the happiest moments like birthday parties, school events, and social gatherings, can come with added worry, as you're constantly checking ingredients, asking questions, and carefully planning to help avoid accidental exposure.

That's why at DBV, we’re committed to advancing a potential treatment option that may reduce the risk and severity of allergic reaction during an accidental exposure.

Visit our website to learn more about our mission and research:
https://bit.ly/47yp7Bs

17/04/2026

Next up in our Peanut Allergy Dictionary series, we’re breaking down the term Epicutaneous Immunotherapy (EPIT): a potential treatment approach that introduces an allergen to the immune system through the skin. This approach may lower the risk of systemic allergic reactions while helping retrain the immune system over time.

Learn more about EPIT; the science behind our VIASKIN® patch technology: https://bit.ly/4b5svUE

13/04/2026

often starts in early childhood and can last into adulthood. For many families, this means years of daily caution, lifestyle changes, and emotional stress.

We understand that food allergy management can feel overwhelming, and that every person’s journey is unique. That’s why we’re developing options that may allow families to take a more proactive approach to care.

As part of our commitment to meeting patients where they are on their journey, we plan to expand our clinical research to include infants aged 6–12 months with peanut allergy.

In addition to clinical evidence across age groups, we believe our patch technology has the potential to change the course of peanut allergy in children. Learn more here: https://bit.ly/4vwi1ck

01/04/2026

Living with in childhood goes beyond simply avoiding certain foods. For many families, it means daily planning, navigating school and social situations, and managing ongoing worry about accidental exposure.

Published research shows that most children do not outgrow peanut allergy, and accidental exposures remain common despite strict avoidance. These realities highlight why additional, proactive treatment approaches continue to be explored.

Discover key facts about peanut allergy treatment in our pop quiz.

27/03/2026

In the U.S. alone, affects ~400,000 children between the ages of 4–7.

For many families, there remains a clear need for additional treatment options that go beyond avoidance alone.

VITESSE, our Phase 3 study in children ages 4–7, evaluated the VIASKIN® Peanut Patch. Recent positive results were announced, followed up additional positive data presented last month.

Stay up to date on our latest progress 👉 Sign up here: https://bit.ly/495uSZD

19/03/2026

management is a journey that evolves throughout childhood. At DBV, we meet children and families where they are on that journey.

Our investigational patch is designed to engage the developing immune system during childhood and build tolerance over time.

Over 1.1 million patches have been administered to more than 1,600 children ages 1 to 7 across our clinical programs. This ongoing research reflects our commitment to developing a treatment for food allergy.

Learn about our ongoing pediatric peanut allergy safety study in toddlers ages 1-3: https://comfort-toddlers-study.com/learnmore/

Adresse

107 Avenue De La République
Châtillon
92320

Site Web

http://www.dbv-technologies.com/

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque DBV Technologies publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.